Inventor · disambiguated record
Manshiu Leung
Also filed as: LEUNG MANSHIU
8 granted patents·10 pending applications·9 citations·filing 2005–2023
81Inventor score
Files withXENOPORT INC6THERAVANCE BIOPHARMA R&D IP LLC4ARBOR PHARMACEUTICALS LLC3ARCUS BIOSCIENCES INC1CUNDY KENNETH C1
Top patents by PatentIndex Score
18 records- 0183US8399513B2Levodopa prodrug mesylate hydrateKARABORNI SAMI·Filed 2009·Granted Mar 19, 2013·4 cites·24 claims
- 0279US8906412B2GABA analog prodrug sustained release oral dosage formsXENOPORT INC·Filed 2014·Granted Dec 9, 2014·3 cites·23 claims
- 0375US10369142B2Combination dosage form of a mu opioid receptor antagonist and an opioid agentTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2017·Granted Aug 6, 2019·1 cites·9 claims
- 0474US10946009B2Combination dosage form of a mu opioid receptor antagonist and an opioid agentTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2019·Granted Mar 16, 2021·0 cites·14 claims
- 0574US2020147019A1Gaba analog prodrug sustained release oral dosage formsARBOR PHARMACEUTICALS LLC·Filed 2019·Application pending·0 cites
- 0672US11452723B2Combination dosage form of a mu opioid receptor antagonist and an opioid agentTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2021·Granted Sep 27, 2022·0 cites·11 claims
- 0770US2020323804A1Gaba analog prodrug sustained release oral dosage formsARBOR PHARMACEUTICALS LLC·Filed 2020·Application pending·0 cites
- 0867US8795725B2GABA analog prodrug sustained release oral dosage formsCUNDY KENNETH C·Filed 2005·Granted Aug 5, 2014·1 cites·19 claims
- 0964US2019247345A1Gaba analog prodrug sustained release oral dosage formsARBOR PHARMACEUTICALS LLC·Filed 2018·Application pending·0 cites
- 1064US2024180947A1Lyophilized formulations of cd73 compoundsARCUS BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 1163US2015072004A1Gaba analog prodrug sustained release oral dosage formsXENOPORT INC·Filed 2014·Application pending·0 cites
- 1262US8722733B2Levodopa prodrug mesylate hydrateXENOPORT INC·Filed 2013·Granted May 13, 2014·0 cites·19 claims
- 1362US2018207117A1Gaba analog prodrug sustained release oral dosage formsXENOPORT INC·Filed 2018·Application pending·0 cites
- 1461US9949941B2GABA analog prodrug sustained release oral dosage formsXENOPORT INC·Filed 2016·Granted Apr 24, 2018·0 cites·8 claims
- 1557US2020361933A1Pharmaceutical compound, salts thereof, formulations thereof, and methods of making and using sameGENENTECH INC·Filed 2019·Application pending·0 cites
- 1652US2016287573A1Combination dosage form of a mu opioid receptor antagonist and an opioid agentTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2016·Application pending·0 cites
- 1745US2010137442A2Sustained Release Particulate Oral Dosage Forms of (R)-Baclofen and Methods of TreatmentXENOPORT INC·Filed 2008·Application pending·0 cites
- 1845US2008206332A1Sustained release oral dosage forms of a prodrug of r-baclofen and methods of treatmentKIDNEY DAVID J·Filed 2008·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Manshiu Leung files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →